AMNEAL PHARMACEUTICALS INC's ticker is AMRX and the CUSIP is 03168L105. A total of 129 filers reported holding AMNEAL PHARMACEUTICALS INC in Q2 2023. The put-call ratio across all filers is 0.38 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $561 | -45.6% | 133 | -60.1% | 0.00% | – |
| Q2 2023 | $1,032 | +271.2% | 333 | +66.5% | 0.00% | – |
| Q1 2023 | $278 | -30.2% | 200 | 0.0% | 0.00% | – |
| Q4 2022 | $398 | – | 200 | 0.0% | 0.00% | – |
| Q3 2022 | $0 | -100.0% | 200 | 0.0% | 0.00% | – |
| Q2 2022 | $1,000 | 0.0% | 200 | 0.0% | 0.00% | – |
| Q1 2022 | $1,000 | 0.0% | 200 | 0.0% | 0.00% | – |
| Q4 2021 | $1,000 | – | 200 | +96.1% | 0.00% | – |
| Q3 2020 | $0 | – | 102 | 0.0% | 0.00% | – |
| Q2 2020 | $0 | – | 102 | 0.0% | 0.00% | – |
| Q1 2020 | $0 | – | 102 | 0.0% | 0.00% | – |
| Q4 2019 | $0 | – | 102 | 0.0% | 0.00% | – |
| Q3 2019 | $0 | -100.0% | 102 | -68.2% | 0.00% | – |
| Q2 2019 | $2,000 | -33.3% | 321 | +92.2% | 0.00% | – |
| Q1 2019 | $3,000 | +50.0% | 167 | +63.7% | 0.00% | – |
| Q4 2018 | $2,000 | 0.0% | 102 | 0.0% | 0.00% | – |
| Q3 2018 | $2,000 | -66.7% | 102 | -70.8% | 0.00% | – |
| Q2 2018 | $6,000 | – | 349 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Fosun International Ltd | 21,521,301 | $83,503,000 | 7.34% |
| Eversept Partners, LP | 2,656,208 | $10,306,087 | 2.29% |
| TPG Group Holdings (SBS) Advisors, Inc. | 16,213,367 | $62,908,000 | 1.13% |
| Prosight Management, LP | 512,659 | $1,989,000 | 0.95% |
| THB ASSET MANAGEMENT | 833,104 | $3,232,000 | 0.90% |
| GLOBEFLEX CAPITAL L P | 251,696 | $977,000 | 0.26% |
| XTX MARKETS LLC | 10,243 | $40,000 | 0.19% |
| HUSSMAN STRATEGIC ADVISORS, INC. | 102,000 | $396,000 | 0.10% |
| PA Capital LLC | 33,874 | $132,000 | 0.09% |
| BOGLE INVESTMENT MANAGEMENT L P /DE/ | 60,900 | $236,000 | 0.07% |